Compact Model T

By | May 25, 2011


The paper

J.S. Rawlings et al., “Chromatin condensation via the condensin II complex is required for peripheral T-cell quiescence,” The EMBO Journal, 30:263-76, 2011. Free F1000 Evaluation

The finding

Naïve T cells remain in a quiescent state, becoming activated only when they encounter their complementary antigen during an immune response. First author Jason Rawlings, then at St. Jude Children’s Research Hospital, found that T cells are maintained in a quiescent state by a nonhistone protein complex involved in chromatin compaction.

The clue

Rawlings first tracked the location of the transcription factor Stat5, which enables the activation of T-cell proliferation during immune response in naïve and active cells. Surprisingly, while Stat5 relocated to the nucleus in both activated and naïve cells, it only induced proliferation in activated T cells. “This was the clue that something was happening at the DNA level,” says Rawlings.

The dead end

The researchers assumed that histone modifications were responsible for making Stat5 promoters inaccessible in naïve cells, but the histones were insoluble in the team’s cell extracts. Using a more stringent method for extracting histones, they saw no difference in histone modification between naïve and activated T cells, raising questions about data relying on standard cell-extraction methods.

The condensin

Rawlings then looked for a mouse with defects in chromatin condensation and T-cell maturation, and found one with a mutant version of the condensin II gene, known for its role in wholesale DNA compaction prior to cell division, showing that condensin rather than histones were responsible.

F1000 evaluators: A. Zajac (Univ of Alabama Birmingham), P. Ferrier (Université de la Méditerranée), W. Bickmore (MRC, Human Genetics Unit)

Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. Does Productivity Diminish Research Quality?
  3. How Plants Evolved Different Ways to Make Caffeine
  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.